Results 51 to 60 of about 2,353,041 (346)

The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

open access: yesiScience, 2021
Summary Vaccines based on mRNA-containing lipid nanoparticles (LNPs) are a promising new platform used by two leading vaccines against COVID-19. Clinical trials and ongoing vaccinations present with varying degrees of protection levels and side effects ...
Sonia Ndeupen   +5 more
semanticscholar   +1 more source

Biophysical analysis of lipidic nanoparticles [PDF]

open access: yesMethods, 2020
Biological nanoparticles include liposomes, extracellular vesicle and lipid-based discoidal systems. When studying such particles, there are several key parameters of interest, including particle size and concentration. Measuring these characteristics can be of particular importance in the research laboratory or when producing such particles as ...
Rozo, Annaïg J.   +4 more
openaire   +2 more sources

Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects

open access: yesFrontiers in Immunology, 2022
Messenger RNA (mRNA) vaccines constitute an emerging therapeutic method with the advantages of high safety and efficiency as well as easy synthesis; thus, they have been widely used in various human diseases, especially in malignant cancers. However, the
Tao Huang   +6 more
semanticscholar   +1 more source

A correlative model to predict in vivo AUC for nanosystem drug delivery with release rate-limited absorption [PDF]

open access: yes, 2012
Purpose. Drug release from nanosystems at the sites of either absorption or effect biophase is a major determinant of its biological action. Thus, in vitro drug release is of paramount importance in gaining insight for the systems performance in vivo ...
Adibkia, Khosro   +6 more
core   +3 more sources

Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration

open access: yesInternational Journal of Molecular Sciences, 2022
PEGylated lipids are one of the four constituents of lipid nanoparticle mRNA COVID-19 vaccines. Therefore, various concerns have been raised on the generation of anti-PEG antibodies and their potential role in inducing hypersensitivity reactions ...
G. Guerrini   +8 more
semanticscholar   +1 more source

Lipid Nanoparticles for Ocular Gene Delivery

open access: yesJournal of Functional Biomaterials, 2015
Lipids contain hydrocarbons and are the building blocks of cells. Lipids can naturally form themselves into nano-films and nano-structures, micelles, reverse micelles, and liposomes.
Yuhong Wang   +2 more
doaj   +1 more source

The role of surface charge in the interaction of nanoparticles with model pulmonary surfactants [PDF]

open access: yes, 2018
Inhaled nanoparticles traveling through the airways are able to reach the respiratory zone of the lungs. In such event, the incoming particles first enter in contact with the liquid lining the alveolar epithelium, the pulmonary surfactant.
Berret, J. -F., Mousseau, F.
core   +4 more sources

Xylem surfactants introduce a new element to the cohesion-tension theory [PDF]

open access: yes, 2016
Vascular plants transport water under negative pressure without constantly creating gas bubbles that would disable their hydraulic systems. Attempts to replicate this feat in artificial systems almost invariably result in bubble formation, except under ...
Do, Aissa YT   +10 more
core   +1 more source

mRNA lipid nanoparticle phase transition

open access: yesBiophysical Journal, 2022
Crucial for mRNA-based vaccines are the composition, structure, and properties of lipid nanoparticles (LNPs) as their delivery vehicle. Using all-atom molecular dynamics simulations as a computational microscope, we provide an atomistic view of the structure of the Comirnaty vaccine LNP, its molecular organization, physicochemical properties, and ...
Trollmann, Marius F.W.   +1 more
openaire   +2 more sources

Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components

open access: yesMolecular Pharmaceutics, 2022
Gene editing mediated by CRISPR/Cas9 systems is due to become a beneficial therapeutic option for treating genetic diseases and some cancers. However, there are challenges in delivering CRISPR components which necessitate sophisticated delivery systems ...
Pardis Kazemian   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy